The Peptide Directory

Best Peptides for Immune Support: Ranked by Evidence (2026)

Thymosin alpha-1 (thymalfasin) is approved in a number of countries outside the US for hepatitis B; LL-37, KPV and thymic bioregulators remain research compounds without FDA approval. The ordering below is by strength of evidence and regulatory status, not by brand.

The ranking

Immune Support peptides ordered by evidence level, then by PubMed-indexed clinical trials (searched October 19, 2026).
CompoundFDA statusEvidence levelPubMed papersTagged trials
ThymalinNot FDA-approved (used in Russia)Clinical trials / approved abroad23412
Thymosin alpha-1Not FDA-approved (approved in some other countries)Clinical trials / approved abroad5911
ThymogenNot FDA-approved (used in Russia)Clinical trials / approved abroad815
VIPNot approved (research only)Preclinical or minimal8,400110
LL-37Not approved (research only)Preclinical or minimal2,54360
TB-500Not approved (research only)Preclinical or minimal6023
BronchogenNot approved (research only)Preclinical or minimal70
ChonlutenNot approved (research only)Preclinical or minimal10
CrystagenNot approved (research only)Preclinical or minimal——
VilonNot approved (research only)Preclinical or minimal——

Why each of the top 6 ranks where it does

1. Thymalin

Clinical trials / approved abroad: Not FDA-approved (used in Russia). PubMed lists 234 records (12 tagged as clinical trials). A recent review: Peptides and Ageing. (Neuro Endocrinol Lett, 2002).

2. Thymosin alpha-1

Clinical trials / approved abroad: Not FDA-approved (approved in some other countries). PubMed lists 59 records (11 tagged as clinical trials) and ClinicalTrials.gov 65 registered studies. A recent trial report: Neoadjuvant immunochemotherapy plus thymalfasin in locally advanced gastric cancer: a prospective clinical trial. (BMC Med, 2026). Registered study: NCT06607926 (na), unknown.

3. Thymogen

Clinical trials / approved abroad: Not FDA-approved (used in Russia). PubMed lists 81 records (5 tagged as clinical trials). A recent trial report: [Thymogen in the complex treatment of inflammatory diseases of the female genital system]. (Akush Ginekol (Mosk), 1992).

4. VIP

Preclinical or minimal: Not approved (research only). PubMed lists 8,400 records (110 tagged as clinical trials) and ClinicalTrials.gov 20 registered studies. A recent review: The role of vasoactive intestinal peptide in pulmonary diseases. (Life Sci, 2023). Registered study: NCT06729606 (phase3), completed.

5. LL-37

Preclinical or minimal: Not approved (research only). PubMed lists 2,543 records (60 tagged as clinical trials) and ClinicalTrials.gov 20 registered studies. A recent review: Human antimicrobial/host defense peptide LL-37 may prevent the spread of a local infection through multiple mechanisms: an update. (Inflamm Res, 2025). Registered study: NCT07280754, not yet recruiting.

6. TB-500

Preclinical or minimal: Not approved (research only). PubMed lists 602 records (3 tagged as clinical trials) and ClinicalTrials.gov 18 registered studies. A recent review: Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. (Sports Med, 2026). Registered study: NCT05555589 (phase3), recruiting.

Where to go next

Overview of the category: Immune Support peptide therapy. Prescribers: clinic directory. Seller facts and prices: vendor directory and price tracker.

Frequently asked questions

Which immune support peptides are FDA-approved?

None of the compounds in this category has an FDA-approved product.

How is this list ordered?

By regulatory status first (FDA-approved, previously approved, in clinical trials or approved abroad, preclinical), then by the number of PubMed-indexed clinical-trial papers. It ranks evidence, not sellers, and no company can pay to change the order.

Can I buy these online?

FDA-approved drugs require a prescription. Products sold as "research peptides" are labeled not for human use and are not FDA-approved; see each compound page for its status and our vendor directory for documented facts about sellers.